SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?


To: Apollo who wrote (5170)8/23/1999 3:51:00 PM
From: Wyätt Gwyön  Respond to of 54805
 
Stan, Besides, proper informed consent of the risks and hazards by the patient should block most risk. After all, it is elective surgery sought by the patient.
I think that statement would have applied equally to those receiving breast implants. As I recall, Dow Corning was set up to find useful things to do with silicone. In addition to breast implants, I believe they developed silicone brain shunts and other devices that benefited patients. Judging by the op-ed page of the Wall St. Journal (not exactly an unbiased source :) as the Dow Corning fiasco played out, there was never definitive and uncontested proof in the scientific community that silicone leaks caused all manner of strange illnesses. But the inundation of lawsuits overwhelmed the company. I and many others would stand to materially benefit from corrective eye surgery, but I just can't help thinking that along the evolutionary course leading to a world in which eyeglasses are only found in museums, there will be serious legal attacks, focusing on those with the deepest pockets. It is certainly admirable what you and others in the medical community do, putting yourself at personal liability risk to save lives. But the kind of legal attacks I would fear would not be those targeted at individual doctors, but rather those aimed at the technological source a la Dow Corning.